This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: M2i Development, Other. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 834,570 Years Active: 2017
Title: Hafid Belhadj-Tahar: Innovator in Chemical Compounds and Dendrimer Technologies
Introduction
Hafid Belhadj-Tahar is a notable inventor based in Toulouse, France. He has made significant contributions to the field of chemical compounds and dendrimer technologies. With a total of 2 patents, his work has implications in medical applications and therapeutic delivery systems.
Latest Patents
Hafid's latest patents include innovative chemical compounds derived from normemantine, which can be utilized as markers of NMDA receptors for imaging studies. These compounds, when marked with fluorine-18, enable advanced scanning techniques in medical research. Additionally, he has developed dendrimer compositions, which involve novel conjugates and methods of synthesis. These dendrimer systems are designed for diagnostic and therapeutic applications, enhancing the delivery of therapeutics and imaging agents.
Career Highlights
Throughout his career, Hafid has worked with M2i Development, where he has contributed to various research projects. His expertise in chemical compounds and dendrimer technologies has positioned him as a key figure in his field.
Collaborations
Hafid has collaborated with notable professionals such as Olivier Guerret and Samuel Dufour, further enriching his research and development efforts.
Conclusion
Hafid Belhadj-Tahar's innovative work in chemical compounds and dendrimer technologies showcases his commitment to advancing medical research. His contributions are paving the way for new diagnostic and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile